Emma J. Haagensen - Concepedia

Author

Emma J. Haagensen

Newcastle University ORCID

Also Known As

E J Haagensen, Emma Haagensen, Emma J Haagensen, Emma J. Haagensen, Haagensen, Emma

Publications

702

Citations

H-Index

Concepts

All Affiliations

Newcastle University University of Dundee Biomedical Research Foundation of the Academy of Athens Manchester Academic Health Science Centre University of Manchester

About

Emma J. Haagensen is an author at Newcastle University specializing in cell biology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	334
2	Cell Biology	3	3	334
3	Pathology	2	2	29
4	Pharmacology	1	1	13
5	Cancer Therapeutics	1	1	13

Emma J. Haagensen

Publications

632

Citations

H-Index

Page 1

	Year	Citations
Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing Panagiotis Galanos, Konstantinos Vougas, David Walter, Nature Cell Biology Genome InstabilitySomatic VariantGeneticsDna ReplicationReplication Licensing	2016	305
Unreplicated DNA remaining from unperturbed S phases passes through mitosis for resolution in daughter cells Alberto Moreno, Jamie T. Carrington, Luca Albergante, Proceedings of the National Academy of Sciences	2016	136
The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibition Emma J. Haagensen, Suzanne Kyle, Gary Beale, British Journal of Cancer	2012	83
Combined PI3K and CDK2 inhibition induces cell death and enhances in vivo antitumour activity in colorectal cancer Gary Beale, Emma J. Haagensen, Huw D. Thomas, British Journal of Cancer	2016	57
The High-Affinity Interaction between ORC and DNA that Is Required for Replication Licensing Is Inhibited by 2-Arylquinolin-4-Amines Nicola J. Gardner, Peter J. Gillespie, Jamie T. Carrington, Cell chemical biology	2017	22
Pre-clinical use of isogenic cell lines and tumours in vitro and in vivo for predictive biomarker discovery; impact of KRAS and PI3KCA mutation status on MEK inhibitor activity is model dependent Emma J. Haagensen, Huw D. Thomas, Clare Mudd, European Journal of Cancer Tumor BiologyOncogenic AgentMedicineIsogenic Cell LinesPathology	2016	16
The Enhanced In Vivo Activity of the Combination of a MEK and a PI3K Inhibitor Correlates with [18F]-FLT PET in Human Colorectal Cancer Xenograft Tumour-Bearing Mice Emma J. Haagensen, Huw D. Thomas, Ian A. Wilson, PLoS ONE Combined Pi3kChemoprevention StrategyPathologyCancer BiologyGlioma	2013	13

Page 1